Results 161 to 170 of about 157,293 (343)

Impact of Opioid and Cannabis Use on Low‐Dose Amitriptyline Efficacy in Cyclical Vomiting Syndrome: A Real‐World Study in the United Kingdom

open access: yesNeurogastroenterology &Motility, EarlyView.
This article presents the outcomes of a three‐tiered outpatient treatment algorithm for the prophylactic management of cyclical vomiting syndrome (CVS). Three key messages: (1) 61% of patients responded to the treatment algorithm, (2) opioid cessation was associated with clinical response to the treatment algorithm (p = 0.03), and (3) a low‐dose ...
Mohsin F. Butt   +4 more
wiley   +1 more source

Measurement of tricyclic antidepressants. Part II. Applications of methodology. [PDF]

open access: bronze, 1980
B A Scoggins   +3 more
openalex   +1 more source

Drug Survival of Drugs Recommended for Irritable Bowel Syndrome: A Retrospective Observational Study

open access: yesNeurogastroenterology &Motility, EarlyView.
ABSTRACT Background There is limited data on how drugs prescribed for functional bowel disorders are re‐prescribed in clinical practice. This study aimed to investigate drug survival rates of different irritable bowel syndrome (IBS) treatments among patients referred to a gastroenterologist.
Alice Sandberg‐Janzon, Pontus Karling
wiley   +1 more source

Drug interactions and possible serotonin syndrome in a patient with fibromyalgia

open access: yesVitae, 2014
Depression associated with fibromyalgia can be treated with selective serotonin reuptake inhibitors (SSRI) as fluoxetine, paroxetine or citalopram; or with serotonin–norepinephrine reuptake inhibitors (duloxetine or milnacipran).
Patricia de Carvalho MASTROIANNI   +2 more
doaj  

Painful Realities: Navigating the Complexities of Head and Neck Cancer Pain

open access: yesOral Diseases, EarlyView.
ABSTRACT Background Head and neck cancer (HNC) and its treatments can cause significant pain, which can profoundly impact patients' quality of life and treatment outcomes. Understanding the full scope of HNC pain is essential for effective management and improved patient care.
Hayden F. Byrd, Zachary A. Kohutek
wiley   +1 more source

The Tricyclic Antidepressant Clomipramine Increases Plasma Glucose Levels of Mice

open access: yesJournal of Pharmacological Sciences, 2003
: Effects of the tricyclic antidepressant clomipramine on plasma glucose levels in mice were studied. Clomipramine at doses ranging 5 – 20 mg/kg elicited significant hyperglycemia in mice.
Yumi Sugimoto, Kiyo Inoue, Jun Yamada
doaj  

Home - About - Disclaimer - Privacy